001323.SHE De Rucci Healthy Sleep Co. Ltd.
- Market cap
- CNY 7.35B
- P/E
- 22.2x
- P/B
- 1.74x
- ROE
- 8.8%
- Dividend yield
- 8.14%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 001323.SHE undervalued?
Graham number001323.SHE trades 30.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
De Rucci Healthy Sleep Co. Ltd. fundamental analysis
No fundamental analysis for De Rucci Healthy Sleep Co. Ltd. yet.
De Rucci Healthy Sleep Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About De Rucci Healthy Sleep Co. Ltd.
De Rucci Healthy Sleep Co., Ltd., together with its subsidiaries, engages in the research, design, development, production, and sale of healthy sleep systems in China, Vietnam, and internationally. The company offers mattresses, bed frames, sofas, beddings, and its supporting home furnishings under the DeRUCCI, CALIAITALIA, CALIA, Envying the home, V6 Home Furnishings, Treca, Kluft, AIRELOOM, S&G Isueno, and SleepDesigns brands. It also engages in the provision of delivery, …
Full company profileDe Rucci Healthy Sleep Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
De Rucci Healthy Sleep Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 3.19B | 3.86B | 4.45B | 6.48B | 5.81B | 5.58B | 5.60B | 5.23B | 4.98B |
| Gross Profit | 1.56B | 2.06B | 2.19B | 2.91B | 2.70B | 2.80B | 2.80B | 2.68B | 2.58B |
| Operating Income | 270M | 427M | 681M | 818M | 819M | 965M | 920M | 512M | 436M |
| EBITDA | 313M | 501M | 746M | 925M | 893M | 1.07B | 1.05B | 901M | 418M |
| Net Income | 216M | 333M | 536M | 686M | 708M | 802M | 767M | 536M | 371M |
| EPS | 0.49 | 0.76 | 1.22 | 1.56 | 1.61 | 1.83 | 1.77 | 1.23 | 0.85 |
| Balance Sheet | |||||||||
| Total Assets | 1.88B | 2.34B | 3.47B | 4.50B | 5.81B | 7.15B | 7.68B | 7.62B | 7.19B |
| Total Liabilities | 1.15B | 1.29B | 1.59B | 1.93B | 1.45B | 2.51B | 3.16B | 3.18B | 2.94B |
| Shareholders' Equity | 730M | 1.05B | 1.88B | 2.57B | 4.36B | 4.64B | 4.52B | 4.44B | 4.23B |
| Cash & Short-term Investments | 246M | 486M | 1.27B | 1.42B | 2.47B | 3.68B | 4.08B | 1.17B | 767M |
| Total Debt | 249M | 31.2M | 972K | 240M | 104M | 512M | 1.08B | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | 358M | 943M | 986M | 995M | 647M | 1.93B | 1.09B | 385M | - |
| Capital Expenditure | 511M | 369M | 456M | 768M | 622M | 396M | 381M | 223M | 244M |
| Free Cash Flow | -153M | 574M | 530M | 226M | 25.7M | 1.54B | 710M | 162M | 4.11M |
| Ratios | |||||||||
| ROE | 29.7% | 31.8% | 28.5% | 26.7% | 16.3% | 17.3% | 17.0% | 12.1% | 8.8% |
| ROA | 11.5% | 14.2% | 15.4% | 15.3% | 12.2% | 11.2% | 10.0% | 7.0% | 5.2% |
| Net Profit Margin | 6.8% | 8.6% | 12.0% | 10.6% | 12.2% | 14.4% | 13.7% | 10.2% | 7.4% |
| Debt to Equity | 0.34x | 0.03x | 0.00x | 0.09x | 0.02x | 0.11x | 0.24x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
De Rucci Healthy Sleep Co. Ltd. dividends
- Dividend yield
- 8.14%
- Forward dividend
- 1.45 CNY
- Payout ratio
- 111.7%
- Ex-dividend date
- Jun 8, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 598M | 1.38 | 111.7% |
| 2024 | CNY 699M | 1.62 | 91.1% |
| 2023 | CNY 400M | 0.91 | 49.9% |
| 2022 | CNY 400M | 0.91 | 56.5% |
| 2021 | - | - | - |
| 2020 | CNY 303M | 0.69 | 56.4% |
| 2019 | CNY 240M | 0.55 | 72.2% |
| 2018 | 7.64M | 0.02 | 3.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.1:1 on Aug 21, 2025.
Who owns De Rucci Healthy Sleep Co. Ltd.
- Insiders 82.49%
- Institutions 2.08%
- Public & others 15.44%
- Shares outstanding 435M
- Free float 73.0M
De Rucci Healthy Sleep Co. Ltd. company profile
- Company name
- De Rucci Healthy Sleep Co. Ltd.
- Ticker
- 001323.SHE
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Household Durables
- Employees
- 4,949
- Fiscal year end
- December
- Address
- No. 1, Houjie Science and Technology Avenue, Dongguan, China, 523900
- Phone
- 86 769 8503 5088
- Website
- derucci.com
About De Rucci Healthy Sleep Co. Ltd.
De Rucci Healthy Sleep Co., Ltd., together with its subsidiaries, engages in the research, design, development, production, and sale of healthy sleep systems in China, Vietnam, and internationally. The company offers mattresses, bed frames, sofas, beddings, and its supporting home furnishings under the DeRUCCI, CALIAITALIA, CALIA, Envying the home, V6 Home Furnishings, Treca, Kluft, AIRELOOM, S&G Isueno, and SleepDesigns brands. It also engages in the provision of delivery, installation, repair, and maintenance; consulting; research and development; and investing services. The company sells its products through its online store. De Rucci Healthy Sleep Co., Ltd. was founded in 2004 and is headquartered in Dongguan, China.
De Rucci Healthy Sleep Co. Ltd. management
4- Mr. Bingkun WangChairman of the Board & GM · born 1972
- Mr. Jiqing YaoVice Chairman of the Board & Deputy GM · born 1965
- Mr. Yonghui DengDeputy GM, CFO, Accounting Supervisor & Secretary · born 1984
- Mr. Yuan Gui ZhaoDeputy General Manager · born 1968